Imaging flow cytometry can be applied to the diagnosis of acute leukaemia. This can be used to detect disrupted PML bodies in acute promyelocytic leukaemia. Nucleophosmin localisation can be determined in acute myeloid leukaemia. Fluorescence in situ hybridisation can be performed on intact phenotyped cells. Potential to integrate all leukaemia diagnostic tests by imaging flow cytometry.